- Home
- MLYS vs QD Comparison
MLYS vs QD Comparison
Compare MLYS & QD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- QD
- Stock Information
- Founded
- MLYS 2019
- QD 2014
- Country
- MLYS United States
- QD China
- Employees
- MLYS N/A
- QD N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- QD Finance: Consumer Services
- Sector
- MLYS Health Care
- QD Finance
- Exchange
- MLYS Nasdaq
- QD Nasdaq
- Market Cap
- MLYS 893.0M
- QD 433.7M
- IPO Year
- MLYS 2023
- QD 2017
- Fundamental
- Price
- MLYS $15.61
- QD $2.90
- Analyst Decision
- MLYS Strong Buy
- QD
- Analyst Count
- MLYS 3
- QD 0
- Target Price
- MLYS $33.00
- QD N/A
- AVG Volume (30 Days)
- MLYS 679.3K
- QD 540.0K
- Earning Date
- MLYS 05-12-2025
- QD 06-12-2025
- Dividend Yield
- MLYS N/A
- QD N/A
- EPS Growth
- MLYS N/A
- QD 177.78
- EPS
- MLYS N/A
- QD 0.07
- Revenue
- MLYS N/A
- QD $29,651,378.00
- Revenue This Year
- MLYS N/A
- QD N/A
- Revenue Next Year
- MLYS N/A
- QD N/A
- P/E Ratio
- MLYS N/A
- QD $42.77
- Revenue Growth
- MLYS N/A
- QD 71.31
- 52 Week Low
- MLYS $8.24
- QD $1.52
- 52 Week High
- MLYS $18.38
- QD $3.34
- Technical
- Relative Strength Index (RSI)
- MLYS 60.58
- QD 62.81
- Support Level
- MLYS $14.03
- QD $2.62
- Resistance Level
- MLYS $15.79
- QD $2.80
- Average True Range (ATR)
- MLYS 0.95
- QD 0.12
- MACD
- MLYS 0.15
- QD 0.04
- Stochastic Oscillator
- MLYS 94.04
- QD 82.91
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About QD Qudian Inc. each representing one
Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.